News-Medical.Net August 4, 2024
Georgetown University Medical Center

Three high-impact steps could be taken by global health leaders to reshape the global regulatory framework and help address the pressing need for equitable access to diagnostics, therapeutics, and vaccines during public health emergencies, say a Georgetown global health law expert and a medical student.

In their “Perspective” published today in the New England Journal of Medicine, Georgetown School of Health professor Sam Halabi, JD, and George O’Hara, a Georgetown medical student and David E. Rogers Student Fellow, say these reforms aim to enhance the capacity of national regulatory bodies, particularly in low- and middle-income countries to ensure timely and safe access to essential medical products.

The U.S. Food and Drug Administration (FDA) and a select group of national regulatory...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Equity/SDOH, Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID, Regulations
Opinion: The U.S. should reform the WHO, not leave it
US health dept providing Moderna $590 mn to speed mRNA bird flu vaccine
Ebola and a Decade of Disparities — Forging a Future for Global Health Equity
Re-Indigenizing and Decolonizing Public Health Systems
Title 42 and its Impact on Immigration and Migrant Families

Share This Article